Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gunter Ladinek
Real-World Treatment of Patients With Multiple Sclerosis Per MS Subtype and Associated Healthcare Resource Use: An Analysis Based on 13,333 Patients in Germany
Neurology and Therapy
Neurology
Related publications
Comorbidities in Multiple Sclerosis: A Descriptive Longitudinal Clustering Analysis of Healthcare Resource Utilization Among MS Patients in IBM Explorys Database
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd40 - Cost of Healthcare Resource Use by Patients With Multiple Sclerosis in France According to Disease Severity
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PND48 Real World Treatment Profile of Patients With Tuberous Sclerosis Complex
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd159 - Dramatic Improvement in Treatment Acceptance Observed in Patients With Multiple Sclerosis Switching Treatment: A Real-World Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
EXPRESS: Treatment Patterns, Healthcare Resource Utilization, and Healthcare Costs Among Patients With Pulmonary Arterial Hypertension in a Real-World US Database
Pulmonary Circulation
Pulmonary
Respiratory Medicine
Real-World Cost of Treatment for Multiple Sclerosis Patients Initiating and Receiving Infused Disease-Modifying Therapies Per Recommended Label in the United States
Journal of Medical Economics
Health Policy
Healthcare Costs and Resource Utilization in Patients With Multiple Sclerosis Relapses Treated With H.P. Acthar Gel®
Advances in Therapy
Medicine
Pharmacology
Pnd96 - Four-Year Resource Use and Costs Associated With Administration and Monitoring of Disease Modifying Drugs in Patients With Multiple Sclerosis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Real-World Effectiveness and Safety of Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients: An Observational Study
PLoS ONE
Multidisciplinary
